Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
ZZERIA PHARMACEUTICAL CO.,LTD. logo
4559TSE Prime

ZERIA PHARMACEUTICAL CO.,LTD.

ゼリア新薬工業 Yahoo Finance

Recent & upcoming events

Aug 6
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 25
Shareholder meeting 21:00
Shareholders' meeting
Venue: 東京都中央区銀座八丁目21番1号 2階ホール (汐留方面・ゼリア指定会場) Details
Add to Google Calendar
May 8
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Nov 5
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
2027
Feb 4
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
May 6
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 29
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥89.16B YoY +2.1%
Operating income ¥12.37B margin 13.9%
Net income ¥8.45B YoY -14.9%
EPS ¥192 YoY -14.9%
P/E —
ROE 8.5% Equity ratio 60% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥95.00B +6.6%
Operating income ¥13.00B +5.1%
Net income ¥10.00B +18.3%
EPS ¥227 +18.3%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q2
Revenue ¥18.30B¥18.37B¥21.24B¥17.81B——
Operating income ¥2.97B¥2.36B¥4.16B¥131M——
Net income ¥2.91B¥2.49B¥3.03B¥-743M——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

創業家 12.1%事業法人 7.4%国内機関 18.5%個人 5.4%未開示 56.7%202120222023202420252026
創業家事業法人国内機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

有限会社伊部 12.1%有限会社伊部日本マスタートラスト信託銀行株式会社 7.3%日本マスタートラスト信託銀行株式会社（信託口）株式会社三菱ＵＦＪ銀行 4.8%株式会社三菱ＵＦＪ銀行伊　部　幸　顕 3.6%伊　部　幸　顕森永乳業株式会社 3.3%森永乳業株式会社株式会社三井住友銀行 3.2%株式会社三井住友銀行株式会社みずほ銀行 3.2%株式会社みずほ銀行三井住友カード株式会社 2%三井住友カード株式会社キッセイ薬品工業株式会社 2%キッセイ薬品工業株式会社ゼリア新薬工業従業員持株会 1.7%ゼリア新薬工業従業員持株会202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
有限会社伊部 5,330,000 12.1% Yuho (EDINET)
日本マスタートラスト信託銀行株式会社（信託口） 3,233,000 7.3% Yuho (EDINET)
株式会社三菱UFJ銀行 2,107,000 4.8% Yuho (EDINET)
伊 部 幸 顕 1,592,000 3.6% Yuho (EDINET)
森永乳業株式会社 1,472,000 3.3% Yuho (EDINET)
株式会社三井住友銀行 1,406,000 3.2% Yuho (EDINET)
株式会社みずほ銀行 1,406,000 3.2% Yuho (EDINET)
三井住友カード株式会社 900,000 2.0% Yuho (EDINET)
キッセイ薬品工業株式会社 867,000 2.0% Yuho (EDINET)
ゼリア新薬工業従業員持株会 766,000 1.7% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

6/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 4.7%
✓ Positive operating cash flow ¥9.96B
✗ ROA improved YoY 6.2% → 4.7%
✓ Operating CF exceeds net income (accrual quality) OCF ¥9.96B / net income ¥8.45B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 56.3% → 60.3%
✓ Current ratio improved 1.28× → 1.48×
✓ No dilution (shares outstanding did not increase) 53,119,190 → 50,119,190
✗ Gross margin improved 73.3% → 73.1%
✗ Asset turnover improved 0.55× → 0.50×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 60.3%
Current ratio 1.5×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 73%
Latest fiscal year result Profit (net income ¥8.45B)

Performance history

Last 10 years
0億円223億円446億円669億円892億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 648646618604554595684757873892
Operating income 45.448.337.440.934.463.790.196.2122124
Ordinary income 44.450.933.038.831.859.475.885.1128110
Net income 35.441.634.529.331.239.662.077.399.484.5
Total assets 1,1441,1611,1041,0421,2191,2431,3501,5051,5921,797
Equity 6356575935275625516577988981,086

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥67¥81¥70¥63¥68¥88¥140¥175¥225¥192
ROE 5.6%6.5%5.5%5.2%5.7%7.1%10.3%10.7%11.7%8.5%
Operating CF 72.488.255.072.568.989.513212212999.6
Investing CF -7.0315.6-28.6-4.05-175-28.9-25.7-39.5-10.5-27.0
Financing CF -89.8-96.3-45.3-58.8112-48.4-74.2-81.2-77.6-59.3
FCF 65.410426.468.5-10660.610682.311972.5

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data